Cargando…
Efficacy of immunotherapy and prognosis in anti‐LGI1 encephalitis patients: A meta‐analysis
OBJECTIVE: To assess the efficacy and safety of immunotherapy for LGI1 antibody encephalitis, and consider the predictors of poor outcomes following immunotherapy. METHODS: We searched PubMed and Embase for articles reporting the immunotherapy data of anti‐LGI1 encephalitis patients. The proportions...
Autores principales: | Kong, Xueying, Gong, Xue, Li, Aiqing, Liu, Yue, Li, Xingjie, Li, Jinmei, Zhou, Dong, Hong, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502619/ https://www.ncbi.nlm.nih.gov/pubmed/37443415 http://dx.doi.org/10.1002/acn3.51847 |
Ejemplares similares
-
Clinical characteristics, long-term functional outcomes and relapse
of anti-LGI1/Caspr2 encephalitis: a prospective cohort study in Western
China
por: Guo, Kundian, et al.
Publicado: (2022) -
Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis
por: Cui, Li-li, et al.
Publicado: (2021) -
Psychiatric Manifestation of Anti-LGI1 Encephalitis
por: Endres, Dominique, et al.
Publicado: (2020) -
Anti-LGI1 encephalitis with initiating symptom of seizures in children
por: Wang, Yang, et al.
Publicado: (2023) -
Fire acupuncture for anti-LGI1 antibody autoimmune encephalitis: a case report
por: Liu, Yu, et al.
Publicado: (2023)